Oral contraceptives prevent the development of endometriosis in the chicken chorioallantoic membrane model

Contraception

Volumn 78, Issue 3, 2008, Pages 257-265

  Nap, Annemiek W ^a   Groothuis, Patrick G ^b   Punyadeera, Chamindie ^c   Klein Hitpass, Ludger ^d   Kamps, Rik ^c   Delvoux, Bert ^e   Dunselman, Gerard A J ^e  

^a Maaslandziekenhuis ^*  (Netherlands)

^b NV ORGANON   (Netherlands)

^c PHILIPS RESEARCH LABORATORIES   (Netherlands)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chorioallantoic membrane model; Endometriosis; Endometrium; Microarray analysis; Oral contraceptives

Indexed keywords

ENDOMETRIAL BLEEDING ASSOCIATED FACTOR; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GELATINASE A; INHIBIN; INHIBIN BETAA; MATRIX METALLOPROTEINASE 26; ORAL CONTRACEPTIVE AGENT; PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; MULTIGENE FAMILY; NONHUMAN; ORAL CONTRACEPTION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ANIMALS; CASE-CONTROL STUDIES; CHICKENS; CHORIOALLANTOIC MEMBRANE; CONTRACEPTIVES, ORAL, HORMONAL; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TISSUE CULTURE TECHNIQUES; YOUNG ADULT;

EID: 48849113806     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.05.003     Document Type: Article

References (37)

1. Sampson J.A. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14 (1927) 422-469
2. Meyer R. Zur Frage der Urnieren-genese von Adenomyomen. Zentral Bl Gynaekol 15 (1923) 577-587
3. Leyendecker G., Herbertz M., Kunz G., and Mall G. Endometriosis results from the dislocation of basal endometrium. Hum Reprod 17 (2002) 2725-2727
4. Levander G., and Normann P. The pathogenesis of endometriosis. An experimental study. Acta Obstet Gynecol Scand 34 (1955) 366-398
5. Sharpe-Timms K.L. Endometrial anomalies in women with endometriosis. Ann N Y Acad Sci 943 (2001) 131-147
6. Vercellini P., Trespidi L., Colombo A., Vendola N., Marchini M., and Crosignani P.G. A gonadotrophin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 60 (1993) 75-79
7. Vigano P., Parazzini F., Somigliana E., and Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol 18 (2004) 177-200
8. The ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update 11 (2005) 513-525
9. Davis L., Kennedy S.S., Moore J., and Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 18 (2007) CD001019
10. Vercellini P., Fedele L., Pietropaolo G., Frontino G., Somigliana E., and Crosignani P.G. Progestogens for endometriosis: forward to the past. Hum Reprod Update 9 (2003) 387-396
11. Maas J.W.M., Groothuis P.G., Dunselman G.A.J., De Goeij A.F.P.M., Struijker Boudier H.A.J., and Evers J.L.H. Development of endometriosis-like lesions after transplantation of human endometrial fragments onto the chick chorioallantoic membrane. Hum Reprod 16 (2001) 627-631
12. Nap A.W., Groothuis P.G., Demir A.Y., et al. Tissue integrity is essential for ectopic implantation of human endometrium in the chicken chorioallantoic membrane. Hum Reprod 18 (2003) 30-34
13. Duerig J., Nueckel H., Huettmann A., et al. Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 101 (2003) 2748-2755
14. Winkel C.A. Evaluation and management of women with endometriosis. Obstet Gynecol 102 (2003) 397-408
15. Sanfilippo J.S., Wakim N.G., Schikler K.N., and Yussman M.A. Endometriosis in association with uterine anomaly. Am J Obstet Gynecol 154 (1986) 39-43
16. Darrow S.L., Vena J.E., Batt R.E., Zielezny M.A., Michalek A.M., and Selman S. Menstrual cycle characteristics and the risk of endometriosis. Epidemiology 4 (1993) 135-142
17. D'Hooghe T.M., Bambra C.S., Suleman M.A., Dunselman G.A.J., Evers J.L.H., and Koninckx P.R. Development of a model of retrograde menstruation in baboons (Papio anubis). Fertil Steril 62 (1994) 635-638
18. Deligdisch L. Hormonal pathology of the endometrium. Mod Pathol 13 (2000) 285-294
19. Parazzini F., Ferraroni M., Bocciolone L., Tozzi L., Rubessa S., and La Vecchia C. Contraceptive methods and risk of pelvic endometriosis. Contraception 49 (1994) 47-55
20. Chiaffarino F., Parazzini F., La Vecchia C., Ricci E., and Crosignani P.G. Oral contraceptive use and benign gynecologic conditions. A review. Contraception 57 (1998) 11-18
21. No authors listed. Oral contraceptives and endometriosis. Contracept Rep 8 (1997) 12-13
22. Kelly R.W., King A.E., and Critchley H.O. Cytokine control in human endometrium. Reproduction 121 (2001) 3-19
23. King A.E., Critchley H.O., and Kelly R.W. The NF-kappab pathway in human endometrium and first trimester decidua. Mol Hum Reprod 7 (2001) 175-183
24. Godkin J.D., and Dore J.J. Transforming growth factor and the endometrium. Rev Reprod 3 (1998) 1-6
25. Chin D., Boyle G.M., Parsons P.G., and Coman W.B. What is transforming growth factor beta (TGF-β)?. Br J Plastic Surg 57 (2004) 215-221
26. Osteen K.G., Igarashi T.M., and Bruner-Tran K.L. Progesterone action in the human endometrium: induction of a unique tissue environment which limits matrix metalloproteinase (MMP) expression. Front Biosci 8 (2003) 78-86
27. Jones R.L., Salamonson L.A., Critchley H.O., Rogers P.A., Affandi B., and Findlay J.K. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol Hum Reprod 6 (2000) 1107-1117
28. Mylonas I., Jeschke U., Wiest I., et al. Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol 122 (2004) 461-471
29. Luisi S., Borges L.E., Lazzeri A., Dell 'Anna A., Severi F.M., and Petraglia F. Vaginally administered estroprogestinic decreases serum inhibin A and B levels and reduces endometrial thickness. Fertil Steril 86 (2006) 1483-1487
30. Vale W., River J., Vaughan J., et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321 (1986) 776-779
31. Mather J.P., Woodruff T.K., and Krummen L.A. Paracrine regulation of reproductive function by inhibin and activin. Proc Soc Exp Biol Med 201 (1992) 1-15
32. De Kretser D.M., Hedger M.P., Loveland K.L., and Phillips D.J. Inhibins, activins and follistatin in reproduction. Hum Reprod Update 8 (2002) 529-541
33. Welt C.K. The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol 14 (2002) 317-323
34. Reis F.M., Di Blasio A.M., Florio P., Ambrosini G., Di Loreto C., and Petraglia F. Evidence for local production of inhibin A and activin A in patients with ovarian endometriosis. Fertil Steril 75 (2001) 367-373
35. Akande A.V., Asselin J., Keay S.D., et al. Inhibin A, inhibin B and activin A in follicular fluid of infertile women with tubal damage, unexplained infertility and endometriosis. Am J Reprod Immunol 43 (2000) 61-69
36. Florio P., Luisi S., Vigano P., et al. Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the menstrual cycle. Hum Reprod 13 (1998) 2606-2611
37. Rombauts L., Donoghue J., Cann L., Jones R.J., and Healy D.L. Activin-A secretion is increased in the eutopic endometrium from women with endometriosis. Aust NZ J Obstet Gynaecol 46 (2006) 148-153